AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $26.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$26.2M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Mar 31, 2026
- 1 added, 2 cutMore cutting
Key stats
Fundamentals Sep 30- Open
- $345.82
- 52-wk high
- $382.54
- High
- $350.00
- 52-wk low
- $178.61
- Low
- $334.01
- Prev close
- $345.82
- Mkt cap
- $9.98B
- P/E
- 42.2x
- Volume
- 298.9K
- Fwd P/E
- 47.0x
- Beta
- 0.54
- P/S
- 22.6x
- P/B
- 7.4x
- Profit margin
- +54.8%
- Op margin
- +49.0%
- ROE
- +20.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about KRYS filings
Are insiders buying or selling Krystal Biotech Inc (KRYS) stock?
Net selling: insiders sold $26.2M and bought $0 of KRYS stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. $18M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Krishnan, Krish S (President and CEO), who sold $9M. The latest filing was on Sep 4, 2026.
Which members of Congress have traded KRYS recently?
None. No member of Congress disclosed a KRYS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this KRYS smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- BR
Bridgewater
$9.5M
added
Sells/Trims (2)
- CI
Citadel
$94.6M
trimmed
- MW
Marshall Wace
$27.6M
trimmed
What insiders are doing
How top traders are positioned
No tracked top-trader positions in KRYS right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 5.3% above what analysts expected.
Earnings per share
$1.70 expected
Reports Nov 2, 2026, in 32 days
Estimates as of Sep 29, 2026
EPS expected
$1.60 to $3.19
Revenue expected
9 analysts
Last 30 days
Analysts cutting estimates
Financials
Is the business strong?
Richly priced and profitable.
- Net margin
- 54.8%
- P/E
- 42.19
- Forward P/E
- 46.95
- Market cap
- $10.0B
Valuation
- P/S22.65
- P/B7.44
Quality
- Operating margin49.0%
- ROE20.1%
- ROA9.4%
Growth
- Beta0.54
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace